none

Gómez-Peralta, F., Abreu, C., Rizzo, M. (2023). GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(8), 108553 [10.1016/j.jdiacomp.2023.108553].

GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms

Rizzo, Manfredi
2023-08-01

Abstract

none
ago-2023
Gómez-Peralta, F., Abreu, C., Rizzo, M. (2023). GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 37(8), 108553 [10.1016/j.jdiacomp.2023.108553].
File in questo prodotto:
File Dimensione Formato  
2023 JDC 2.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 347.35 kB
Formato Adobe PDF
347.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/620429
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact